"Poland remains the largest clinical trials market in CEE – however - both patient participation and site penetration rates indicate a potential for growth."
In Conversation
"Overall, we want to create a more stable system that does not fluctuate so rapidly; therefore, the reimbursement list will be launched each quarter, rather than…
"The national program has been developed based on the initial model designed by the European project for rare disease plans."
"The country has great quality of care, especially in the fields of cardiology, cardio-surgery, neuro-surgery, transplantology and replantation of limbs."
"We must focus heavily on legislation and the amendments made to the reimbursement act in regard to ensuring the payback system is acceptable from an industry…
The general director of Actavis Poland talks about competing in an intense generics market, and the company's potential in Poland given the country's 2012 Reimbursement Act.
AstraZeneca’s General Manager in Poland discuses AstraZeneca’s strategic realignment to become a highly specialized biotech company after 20 years of presence in Poland. He stresses the…
Novascon Pharmaceuticals is the second fastest growing company in the OTC/dietary supplement market in Poland. Its founder shares the reasons behind this success, including his strategy…
Omega Pharma is a pharmacist champion and one of the fastest growing OTC companies in Poland. Its General Manager in Poland discusses the shift taking place…
Schulke Poland’s General Manager wants the affiliate: “to be recognized as a high quality “one stop shop” for hygiene and disinfection. He also comments: “Poland is…
The department of innovation and industry under the Ministry of Economy has been preparing a new project called: “
Bristol-Myers Squibb’s General Manager in Poland stresses the urgent need to allow more innovative drugs to fight against deadly diseases, especially in the field of immune-oncology…
